Diphtheria, Tetanus, Acellular Pertussis, Poliovirus & Haemophilus influenzae type b Vaccine (DTaP-IPV-Hib) [Infanrix-IPV+Hib]
Availability of ACE Drug Guidance
No
Biologics Drug Information Overview
No
Post-marketing information
Dear Healthcare Professional Letters
Subsidy Information and Financing Scheme
Subsidised Vaccine List
Active ingredients: Vaccine Diphtheria | Diphtheria Vaccine | Vaccine Tetanus | Tetanus Vaccine | Vaccine Pertussis | Pertussis Vaccine | Vaccine Poliovirus | Poliovirus Vaccine | Vaccine Haemophilus Influenzae Type B | Haemophilus Influenzae Type B Vaccine | Diphtheria, Tetanus, Acellular Pertussis, Poliovirus & Haemophilus influenzae type b Vaccine (DTaP-IPV-Hib)
General information
Subsidy Information and Financing Scheme
[SVL] Diphtheria, Tetanus, Acellular Pertussis, Poliovirus & Haemophilus influenzae type b Vaccine (DTaP-IPV-Hib) (Infanrix-IPV+Hib) Injection, Diphtheria Toxoid Vaccine minimum 30 international units/0.5 mL + Tetanus Toxoid Vaccine minimum 40 international units/0.5 mL + Pertussis Toxoid Vaccine 25 micrograms/0.5 mL + Filamentous Haemagglutinin 25 micrograms/0.5 mL + Pertactin 8 micrograms/0.5 mL + Poliovirus Vaccine (inactivated) Type-1 40 D-antigen unit/0.5 mL + Poliovirus Vaccine (inactivated) Type-2 8 D-antigen unit/0.5 mL + Poliovirus Vaccine (inactivated) Type-3 32 D-antigen unit/0.5 mL + Haemophilus influenzae type B Vaccine 10 micrograms/0.5 mL
National Childhood Immunisation Schedule (NCIS)
Drug Guidance for Subsidy
Not Applicable
Post Marketing Information
General Availability in Public Healthcare Institution
Note:
General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals (opens in new tab) or Polyclinics (opens in new tab) for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.
Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration
Availability information
Formulation | Public Healthcare Institution |
|---|---|
Infanrix-IPV+Hib Injection, Diphtheria Toxoid Vaccine minimum 30 international units/0.5 mL + Tetanus Toxoid Vaccine minimum 40 international units/0.5 mL + Pertussis Toxoid Vaccine 25 micrograms/0.5 mL + Filamentous Haemagglutinin 25 micrograms/0.5 mL + Pertactin 8 micrograms/0.5 mL + Poliovirus Vaccine (inactivated) Type-1 40 D-antigen unit/0.5 mL + Poliovirus Vaccine (inactivated) Type-2 8 D-antigen unit/0.5 mL + Poliovirus Vaccine (inactivated) Type-3 32 D-antigen unit/0.5 mL + Haemophilus influenzae type B Vaccine 10 micrograms/0.5 mL |
|
Registered Product(s) Information
Clinical and product info
Clinical info | Product Info |
|---|---|
Information under the Indication, Dosage and Contraindication sections are extracted from the relevant Package Insert/Patient Information Leaflet of the product available on HSA Infosearch. For more information, please refer to the product's Package Insert/ Patient Information Leaflet available on HSA Infosearch (opens in new tab). The information provided is for informational purposes only, and is not exhaustive. The information provided is not a substitute for professional medical advice. Please consult a qualified healthcare provider for any medical advice. | Information available here are product details as registered with the HSA. As this website is updated monthly, please refer to HSA Infosearch (opens in new tab) for the most updated product information. |
Intramuscular
* Clinical information is available for this product.